Dr. Victor R. de la Rosa

Co-founder and Chief Executive Officer

Victor R. de la Rosa studied Chemistry at the University of Valladolid (UVa; Spain) and Ghent University (UGent; Belgium), where he spent a year within the Erasmus programme. Upon graduating in 2010, he returned to Ghent to conduct a PhD on poly(2-oxazoline)s and supramolecular chemistry under the supervision of Prof. Richard Hoogenboom.

In 2015, he was awarded an IWT post-doctoral grant (now VLAIO) to create a spin-off company based on the poly(2-oxazoline) platform. He developed scalable processes for the production of high-quality poly(2-oxazoline)s, with a special focus on biomedical applications. He is co-inventor in several patents and has co-authored more than 20 scientific publications, mostly in the poly(2-oxazoline)s field.

Early 2018, Victor co-founded the spin-off company Avroxa bvba, dedicated to the design and production of poly(2-oxazoline)s under the Ultroxa brand name. Victor currently leads a team dedicated to poly(2-oxazoline) production and applied research, being responsible for the operations and R&D activities of Avroxa.

[email protected]
Phone: +32 487 196 739

ULTROXA®  team An Van Den Bulcke

Dr. An Van Den Bulcke


An Van Den Bulcke holds a Ph.D in Chemistry (Polymer Synthesis) and has an industrial career in product development and R&D management. In 2011 she started as Business Developer at ChemTech, the Chemistry Business and Valorisation cluster at Ghent University.

An’s areas of expertise include: research & innovation management, technology transfer, project portfolio management, out-licensing, intellectual property, technology and business development.

An is co-founder and member of the management board of the CBI-cluster, “Chemistry to foster Biology Innovation” an inter-university initiative linking chemical expertise in Flanders (UA, KULeuven, UGent, UHasselt and VUB) with the biology community. She is part of the knowledge transfer committee of the Cancer Research Institute Ghent (CRIG).

E-mail: [email protected]
Phone: +32 474 812 381

ULTROXA® team Richard Hoogenboom

Prof. Dr. Richard Hoogenboom

Co-founder and Scientific Advisor

Richard Hoogenboom studied chemical engineering at the Eindhoven University of Technology (TU/e; Netherlands). In 2005, he obtained his PhD under the supervision of Ulrich S. Schubert (TU/e) and continued working as project leader for the Dutch Polymer Institute; partly combined with a part-time position as Senior Product Developer at Dolphys Medical.

After postdoctoral training with Martin Möller at the RWTH Aachen (Humboldt fellowship; 2008) and Roeland J. M. Nolte at the Radboud University Nijmegen (NWO veni-grant; 2009), he was appointed as associate professor at Ghent University in 2010 and promoted to full professor in 2014.

His research interests include poly(2-oxazoline)s, stimuli-responsive polymers, and supramolecular materials, fields in which he is (co)inventor in more than 10 patent families and has co-authored over 300 scientific publications. He is currently associate editor for European Polymer Journal and Australian Journal of Chemistry.

E-mail: [email protected]
Phone: +32 926 444 82

Our Advisory Board

ULTROXA® team Ann Meulemans

Ann Meulemans

CEO and founder of 2Bridge and Octimet Oncology
25 years’ experience in drug discovery/drug development
ULTROXA® team Annie Van Broeckhoven

Dr. Annie Van Broeckhoven

CEO and founder of Q-Biologicals
>25 years’ experience in manufacturing of Biologicals
ULTROXA® team Andreas Kopke

Andreas Kopke

Business Developer Pharma & Biotech as Consultant in BioExpert
20 years’ experience in Business Development